News Releases

April 27, 2022

Creating a novel population of mutant tissues helps scientists deduce the cause of polycystic kidney disease and other cilia-linked illnesses.

April 25, 2022

If medication supplies dwindle, hospitals worldwide should prioritize health equity and people at greatest risk, a new paper argues.

April 25, 2022

A Phase 3 clinical trial found that the second-generation vaccine generates high levels of neutralizing antibodies.

April 20, 2022

Project aims to create a genome reference that represents the genetic diversity of all the populations on Earth. 

April 19, 2022

A trial will test three evidence-based counseling therapies to see if one, or more than one in combination, results in better outcomes.

April 18, 2022

If resource shortages became dire, triage team members would have to deprioritize some patients from getting life-sustaining care.

April 11, 2022

A one-shot vaccine schedule could contribute greatly to the elimination of cervical cancer worldwide, researchers say.

April 7, 2022

The study's lead author expresses surprise that patients still under the care of cancer specialists would forgo these diagnostic exams.  

April 6, 2022

The Seattle Tuberculosis Research Advancement Center will promote and coordinate studies across institutions in the city.

April 4, 2022

Carrying behaviors differ from those seen among urban youths, offering more specific context to firearm-prevention programs. 

Pages